KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q3 2025 value amounting to $7.6 million.

  • Ginkgo Bioworks Holdings' Amortizatization of Intangibles rose 45.04% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 2316.34%. This contributed to the annual value of $28.1 million for FY2024, which is 77.0% down from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Amortizatization of Intangibles is $7.6 million, which was up 45.04% from $7.5 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Amortizatization of Intangibles ranged from a high of $10.9 million in Q3 2022 and a low of $3.7 million during Q4 2023
  • Moreover, its 4-year median value for Amortizatization of Intangibles was $7.5 million (2025), whereas its average is $7.5 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Amortizatization of Intangibles crashed by 4895.21% in 2023 and then skyrocketed by 10326.26% in 2024.
  • Ginkgo Bioworks Holdings' Amortizatization of Intangibles (Quarter) stood at $7.2 million in 2022, then tumbled by 48.95% to $3.7 million in 2023, then soared by 103.26% to $7.5 million in 2024, then increased by 1.43% to $7.6 million in 2025.
  • Its Amortizatization of Intangibles stands at $7.6 million for Q3 2025, versus $7.5 million for Q2 2025 and $7.4 million for Q1 2025.